Evidence map›Paper›PMID 38238612›Full record

ArticleVirus genes2024

Two novel phages, Klebsiella phage GADU21 and Escherichia phage GADU22, from the urine samples of patients with urinary tract infection.

Hanife Salih Doğan, Abdulkerim Karaynir, Ülkü İrem Yilmaz, Bilgin Bahadır Başgöz, Tuğrul Hoşbul, Bülent Bozdoğan

Abstract read
PubMed Publisher
In one paragraph

Article in Virus genes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Hanife Salih DoğanRecombinant DNA and Recombinant Protein Center (REDPROM), Aydın Adnan Menderes University, Aydın, Turkey. hanifesalih94@gmail.com.ORCID https://orcid.org/0000-0003-2141-0669
Abdulkerim KaraynirRecombinant DNA and Recombinant Protein Center (REDPROM), Aydın Adnan Menderes University, Aydın, Turkey.ORCID https://orcid.org/0000-0003-0511-0869
Ülkü İrem YilmazDepartment of Medical Services and Techniques, Gülhane Vocational School of Health, Health Sciences University, Ankara, Turkey.ORCID https://orcid.org/0000-0002-9531-0479
Bilgin Bahadır BaşgözGülhane School of Medicine, Department of Internal Medicine, Health Sciences University, Ankara, Turkey.ORCID https://orcid.org/0000-0002-5795-533X
Tuğrul HoşbulGülhane School of Medicine, Department of Medical Microbiology, Health Sciences University, Ankara, Turkey.ORCID https://orcid.org/0000-0002-0150-4417
Bülent BozdoğanRecombinant DNA and Recombinant Protein Center (REDPROM), Aydın Adnan Menderes University, Aydın, Turkey.ORCID https://orcid.org/0000-0003-2469-9728
Sağlık Bilimleri Üniversitesi · TRAdnan Menderes University · TRRecombinant Technologies (United States) · US

Funding

The council of higher education YOK 100/2000 fellowship programTürkiye Bilimsel ve Teknolojik Araştırma Kurumu 2211/A National PhD Scholarship Program
6 · The paper itself

Abstract

Phages are found in a wide variety of places where bacteria exist including body fluids. The aim of the present study was to isolate phages from the urine samples of patients with urinary tract infection. The 10 urine samples were cultured to isolate bacteria and also used as phage sources against the isolated bacteria. From 10 urine samples with positive cultures, 3 phages were isolated (33%) and two of them were further studied. The Klebsiella phage GADU21 and Escherichia phage GADU22 phages infected Klebsiella pneumonia and Escherichia coli, respectively. Among the tested 14 species for host range analysis, the Klebsiella phage GADU21 was able to infect two species which are Klebsiella pneumonia and Proteus mirabilis, and Escherichia phage GADU22 was able to infect four species which are Shigella flexneri, Shigella sonnei and Escherichia coli. Among different isolates of the indicator bacteria for each phage, GADU21 infected half of the tested 20 Klebsiella pneumonia isolates while GADU22 infected 85% of the tested 20 E. coli isolates. The genome sizes and GC ratios were 75,968 bp and 44.4%, and 168,023 bp and 35.3% for GADU21 and GADU22, respectively. GADU21 and GADU22 were both lytic and had no antibiotic resistance and virulence genes. GADU21 was homologue with Klebsiella phage vB_KpP_FBKp27 but only 88% of the genome was covered by this phage. The non-covered parts of the GADU21 genome included genes for tail-fiber-proteins and HNH-endonuclease. GADU22 had 94.8% homology with Escherichia phage vB_Eco_OMNI12 and had genes for immunity proteins. Phylogenetic analysis showed GADU21 and GADU22 were members of Schitoviridae family and Efbeekayvirus genus and Straboviridae family and Tevenvirinae genus, respectively. VIRIDIC analysis classified these phages in new species clusters. Our study demonstrated the possibility to use infected body fluids as phage sources to isolate novel phages. GADU21 is the first reported Klebsiella phage isolated from human body fluid. The absence of virulence and antibiotic resistance genes in their genomes makes the phages a potential therapeutic tool against infections.

Indexed as

BacteriophagesPneumoniaUrinary Tract InfectionsBacteriaEscherichia coliHumansKlebsiellaKlebsiella pneumoniaePhylogenyEscherichia phageKlebsiella phagePhagesPhage sourcesUrinary tract infections (UTIs)

Identifiers

PMID38238612
OpenAlexW4390965118

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.